This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Fluoroquinolones May Increase Risk for Retinal Detachment, Study Finds
By News Staff
Study researchers used the British Columbia Linked Health Database, which includes data on about 4.5 million people, to identify a nested case-control cohort of all patients who visited an ophthalmologist in the province of British Columbia between January 2000 and December 2007. Of the 989,591 individuals that comprised this group, researchers identified 4,384 cases of retinal detachment and 43,840 corresponding controls. Patients with a physician service claim or procedure code related to endophthalmitis were excluded from the study.
- A recent study in JAMA: The Journal of the American Medical Association found that oral fluoroquinolones raise the risk of retinal detachment in current users of the drugs.
- The antibiotics previously have been found to have a destructive effect on connective tissue, which the study authors suggest could be the source of the problem.
- The authors estimate that 1,440 cases of retinal detachment diagnosed each year in the United States may be attributed to oral fluoroquinolone use.
According to the study report, "Cases were more likely to be male and were more likely to have myopia (or) diabetes or have received cataract surgery." Current users of the drugs averaged 4.8 days from the first fluoroquinolone prescription to retinal detachment. Ciprofloxacin contributed to the most cases of retinal detachment in the study, followed by levofloxacin and norfloxacin.
Although the authors acknowledge that the precise mechanism of retinal detachment with fluoroquinolones is unknown, "The putative mechanism behind a possible fluoroquinolone-induced retinal detachment may be through the destructive effect of the drugs on collagen and connective tissue," they note.
Notably, fluoroquinolones previously have been linked to tendon rupture, which was one of the findings that spurred this follow-up study. Given that the retina is attached to the cortical vitreous by a matrix of collagen fibers, and that fluoroquinolones "have been shown to interfere with collagen synthesis and disrupt the extracellular matrix outside the retina," the authors postulate that "damage from fluoroquinolones to collagen and connective tissue on the long bones may also translate to the same type of damage to other types of connective tissue, including that of the vitreous and vitreous cortex."
Overall, the annual incidence of retinal detachment in the United States is estimated to be 12 per 100,000 patients. Given an exposure prevalence of about 10 percent and assuming a similar risk increase in the general population, the study authors estimate the population-attributable risk to be about 4 percent. Thus, they estimate that 1,440 cases of retinal detachment diagnosed each year in the United States may be attributed to oral fluoroquinolone use.
PubMed Health: Retinal Detachment